FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973086049> ?p ?o ?g. }

• W2973086049 endingPage "5493" @default.
• W2973086049 startingPage "5483" @default.
• W2973086049 abstract "Leukemia cells can develop resistance to apoptosis induced by chemotherapeutic agents. Concomitant multidrug resistance of cells remains the greatest clinical obstacle in the effective treatment of blood and solid tumors. Natural products have been identified that possess the capacity to modulate chemotherapeutic resistance and induce apopotosis. In this study, we generated adriamycin-resistant K562 leukemia (K562/RA) cells and compared the responses of sensitive and resistant leukemia cells to the natural products arsenic trioxide (ATO) and resveratrol (Rsv), with a view to determining whether Rsv potentiates the sensitivity of drug-resistant cells to ATO-induced apoptosis and the associated molecular mechanisms. Our results showed that resistance of K562/RA cells induced by adriamycin treatment was significantly higher (115.81-fold) than that of parental K562 cells. Simultaneously, K562/RA cells were cross-resistant to multiple agents, with the exception of ATO. Rsv enhanced the sensitivity of K562/RA cells to ATO and reduced the required dose of ATO as well as associated adverse reactions by promoting the proliferation inhibitory and apoptosis-inducing effects of ATO, which may be associated with reduced expression of the drug resistance genes mdr1/P-gp, mrp1/MRP1 and bcrp/BCRP, as well as the apoptotic inhibitory genes bcl-2, NF-κB and P53, and conversely, activation of caspase-3. Our collective findings indicate that ATO and Rsv synergistically enhance the sensitivity of drug-resistant leukemia cells to apoptosis." @default.
• W2973086049 created "2019-09-19" @default.
• W2973086049 creator A5008788372 @default.
• W2973086049 creator A5013881064 @default.
• W2973086049 creator A5021449354 @default.
• W2973086049 creator A5022233225 @default.
• W2973086049 creator A5034278897 @default.
• W2973086049 creator A5034953327 @default.
• W2973086049 creator A5039383725 @default.
• W2973086049 creator A5042235591 @default.
• W2973086049 creator A5048379858 @default.
• W2973086049 creator A5052779340 @default.
• W2973086049 creator A5083681547 @default.
• W2973086049 creator A5084330834 @default.
• W2973086049 creator A5086003530 @default.
• W2973086049 date "2019-01-01" @default.
• W2973086049 modified "2023-10-01" @default.
• W2973086049 title "A Novel Resveratrol-Arsenic Trioxide Combination Treatment Synergistically Induces Apoptosis of Adriamycin-Selected Drug-Resistant Leukemia K562 Cells" @default.
• W2973086049 cites W157402533 @default.
• W2973086049 cites W1600660353 @default.
• W2973086049 cites W1984789674 @default.
• W2973086049 cites W1985313300 @default.
• W2973086049 cites W1987154876 @default.
• W2973086049 cites W1989155188 @default.
• W2973086049 cites W1995338674 @default.
• W2973086049 cites W1999824048 @default.
• W2973086049 cites W2014573606 @default.
• W2973086049 cites W2039003881 @default.
• W2973086049 cites W2050625990 @default.
• W2973086049 cites W2053111664 @default.
• W2973086049 cites W2068380884 @default.
• W2973086049 cites W2077872976 @default.
• W2973086049 cites W2077885909 @default.
• W2973086049 cites W2098067696 @default.
• W2973086049 cites W2100969980 @default.
• W2973086049 cites W2107277218 @default.
• W2973086049 cites W2116500735 @default.
• W2973086049 cites W2129338773 @default.
• W2973086049 cites W2138910309 @default.
• W2973086049 cites W2139535867 @default.
• W2973086049 cites W2173789978 @default.
• W2973086049 cites W2192080449 @default.
• W2973086049 cites W2327657768 @default.
• W2973086049 cites W2517127436 @default.
• W2973086049 cites W2581968211 @default.
• W2973086049 cites W2733836692 @default.
• W2973086049 cites W2768331948 @default.
• W2973086049 cites W2781113055 @default.
• W2973086049 cites W2095953792 @default.
• W2973086049 doi "https://doi.org/10.7150/jca.34506" @default.
• W2973086049 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6775695" @default.
• W2973086049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31632492" @default.
• W2973086049 hasPublicationYear "2019" @default.
• W2973086049 type Work @default.
• W2973086049 sameAs 2973086049 @default.
• W2973086049 citedByCount "8" @default.
• W2973086049 countsByYear W29730860492020 @default.
• W2973086049 countsByYear W29730860492021 @default.
• W2973086049 countsByYear W29730860492022 @default.
• W2973086049 countsByYear W29730860492023 @default.
• W2973086049 crossrefType "journal-article" @default.
• W2973086049 hasAuthorship W2973086049A5008788372 @default.
• W2973086049 hasAuthorship W2973086049A5013881064 @default.
• W2973086049 hasAuthorship W2973086049A5021449354 @default.
• W2973086049 hasAuthorship W2973086049A5022233225 @default.
• W2973086049 hasAuthorship W2973086049A5034278897 @default.
• W2973086049 hasAuthorship W2973086049A5034953327 @default.
• W2973086049 hasAuthorship W2973086049A5039383725 @default.
• W2973086049 hasAuthorship W2973086049A5042235591 @default.
• W2973086049 hasAuthorship W2973086049A5048379858 @default.
• W2973086049 hasAuthorship W2973086049A5052779340 @default.
• W2973086049 hasAuthorship W2973086049A5083681547 @default.
• W2973086049 hasAuthorship W2973086049A5084330834 @default.
• W2973086049 hasAuthorship W2973086049A5086003530 @default.
• W2973086049 hasBestOaLocation W29730860491 @default.
• W2973086049 hasConcept C114851261 @default.
• W2973086049 hasConcept C133936738 @default.
• W2973086049 hasConcept C171122931 @default.
• W2973086049 hasConcept C185592680 @default.
• W2973086049 hasConcept C190283241 @default.
• W2973086049 hasConcept C203014093 @default.
• W2973086049 hasConcept C2776816829 @default.
• W2973086049 hasConcept C2778461978 @default.
• W2973086049 hasConcept C2780386689 @default.
• W2973086049 hasConcept C502942594 @default.
• W2973086049 hasConcept C55493867 @default.
• W2973086049 hasConcept C71924100 @default.
• W2973086049 hasConcept C86803240 @default.
• W2973086049 hasConcept C89423630 @default.
• W2973086049 hasConcept C98274493 @default.
• W2973086049 hasConceptScore W2973086049C114851261 @default.
• W2973086049 hasConceptScore W2973086049C133936738 @default.
• W2973086049 hasConceptScore W2973086049C171122931 @default.
• W2973086049 hasConceptScore W2973086049C185592680 @default.
• W2973086049 hasConceptScore W2973086049C190283241 @default.
• W2973086049 hasConceptScore W2973086049C203014093 @default.
• W2973086049 hasConceptScore W2973086049C2776816829 @default.
• W2973086049 hasConceptScore W2973086049C2778461978 @default.

• next